Thermo Fisher Scientific (TMO) EPS (Basic) (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported EPS (Basic) for 18 consecutive years, with $4.74 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EPS (Basic) rose 10.71% year-over-year to $4.74; the trailing twelve-month figure through Jun 2026 stood at $18.98 (up 8.94% YoY), and the FY2025 full-year result was $17.93, up 8.14% from the prior year.
• EPS (Basic) rose to $4.74 in Q2 2026 per TMO's latest filing, from $4.47 in the prior quarter.
• Across five years, EPS (Basic) topped out at $5.65 in Q2 2022 and bottomed at $3.34 in Q2 2023.
• Historically, EPS (Basic) has averaged $4.27 across 5 years, with a median of $4.26 in 2022.
• The widest YoY moves for EPS (Basic): up 16.5% in 2023, down 40.9% in 2023.
• Over 5 years, EPS (Basic) stood at $4.02 in 2022, then grew by 5.03% to $4.22 in 2023, then grew by 13.45% to $4.79 in 2024, then gained by 10.74% to $5.31 in 2025, then slipped by 10.73% to $4.74 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $4.74, $4.47, and $5.31 for Q2 2026, Q1 2026, and Q4 2025 respectively.